Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| coagulation factor Xa | A blood coagulation factor formed from the proenzyme factor X by limited proteolysis. Factor X is a glycoprotein composed of a heavy chain and a light chain, which are generated from a precursor protein by the excision of the tripeptide RKR and held together by one or more disulfide bonds. The activated factor Xa converts prothrombin to thrombin in the presence of factor Va, Ca2+ and phospholipids. Scutelarin (EC 3.4.21.60) has similar specificity, but does not require factor Va. Group: Enzymes. Synonyms: thrombokinase; prothrombase; prothrombinase; activated blood-coagulation factor X; autoprothrombin C; thromboplastin; plasma thromboplastin; factor Xa; activated Stuart-Prower factor; activated factor X. Enzyme Commission Number: EC 3.4.21.6. CAS No. 9002-5-5. Factor Xa. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4150; coagulation factor Xa; EC 3.4.21.6; 9002-05-5; thrombokinase; prothrombase; prothrombinase; activated blood-coagulation factor X; autoprothrombin C; thromboplastin; plasma thromboplastin; factor Xa; activated Stuart-Prower factor; activated factor X. Cat No: EXWM-4150. |  |
| 1-(4-Methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester | 1-(4-Methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester is a derivative of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg, 25mg. Molecular Formula: C22H18N4O6, Molecular Weight: 434.4. US Biological Life Sciences. |  Worldwide |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid is an intermediate of the synthesis of Apixaban (A726700) which is an inhibitor of blood coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. CAS No. 503614-92-4. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C25H24N4O5, Molecular Weight: 460.48. US Biological Life Sciences. | Worldwide |
| 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid | 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid is a derivative of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C25H22N4O5, Molecular Weight: 458.47. US Biological Life Sciences. | Worldwide |
| 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester | 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-6,7-dihydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid Ethyl Ester is a derivative of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 2.5mg, 5mg. Molecular Formula: C27H26N4O5, Molecular Weight: 486.52. US Biological Life Sciences. | Worldwide |
| 1-(4-Nitrophenyl)-2-piperidinone | 1-(4-Nitrophenyl)-2-piperidinone is used in the synthesis of inhibitors of blood coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. CAS No. 38560-30-4. Pack Sizes: 500mg, 1g. Molecular Formula: C11H12N2O3. US Biological Life Sciences. | Worldwide |
| 3-Chloro-1-(2-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 3-Chloro-1-(2-nitrophenyl)-5,6-dihydropyridin-2(1H)-one is a metabolite of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg, 50mg. Molecular Formula: C11H9ClN2O3, Molecular Weight: 252.65. US Biological Life Sciences. | Worldwide |
| 3-(Morpholinyl)-N-(4-nitrophenyl)-5,6-dihydropyridin-2-one | 3-(Morpholinyl)-N-(4-nitrophenyl)-5,6-dihydropyridin-2-one is a reagent in the synthesis of 4,5-dehydro Apixaban (D229385) an impurity of Apixaban (A726700), a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation. Group: Biochemicals. Grades: Highly Purified. CAS No. 503615-03-0. Pack Sizes: 50mg, 100mg. Molecular Formula: C15H17N3O4, Molecular Weight: 303.31. US Biological Life Sciences. | Worldwide |
| [ (4-Methoxyphenyl) methyl] triphenylphosphonium Chloride | [ (4-Methoxyphenyl) methyl] triphenylphosphonium Chloride is used in the synthesis of novel blood coagulation factor Xa inhibitors and various antiplatelet aggregation pharmaceuticals. Group: Biochemicals. Alternative Names: (p-Methoxybenzyl) triphenylphosphonium Chloride; (p-Methoxybenzyl) triphenylphosphonium, Chloride; [ (4-Methoxyphenyl) methyl] triphenylphosphonium Chloride; (4-Methoxybenzyl) triphenylphosphonium Chloride; [ (4-Methoxyphenyl) methyl] triphenylphosphonium Chloride. Grades: Highly Purified. CAS No. 3462-97-3. Pack Sizes: 1g, 10g, 50g. Molecular Formula: C26H24ClOP, Molecular Weight: 418.89. US Biological Life Sciences. | Worldwide |
| Apixaban Acid-[13C,d3] | Apixaban Acid-[13C,d3] is the labelled analogue of Apixaban Acid, which is an intermediate of the synthesis of Apixaban, an inhibitor of blood coagulation factor Xa. Synonyms: Apixaban Acid-13C,D3; 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic Acid-13C,d3; Apixaban carboxylic acid-13C,d3. Grade: ≥99% by HPLC; 99% atom 13C; 99% atom D. Molecular formula: C24[13C]H21D3N4O5. Mole weight: 464.49. |  |
| BMS-740808 | BMS-740808 is a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa with Ki of 0.03 nM. Synonyms: 1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-[2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]phenyl]phenyl]-3-(trifluoromethyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one; BMS 740808; BMS-740808; BMS740808; UNII-LDD74E663F. Grade: >99%. CAS No. 280118-23-2. Molecular formula: C31H27F3N6O3. Mole weight: 588.58. | |
| Boc-Ile-Glu-Gly-Arg-AMC | Boc-IEGR-AMC is a specific, highly fluorogenic substrate for clotting enzyme factor Xa (coagulation factor Xa). Synonyms: Boc-ile-glu-gly-arg-7-amido-4-methylcoumarin; 7-(Nalpha-tert-butyloxycarbonyl-L-isoleucyl-L-glutamylglycyl-L-arginyl)amino-4-methylcoumarin. Grade: >97%. CAS No. 65147-06-0. Molecular formula: C34H50N8O10. Mole weight: 730.81. | |
| Bovine factor IX | The zymogen factor IX is a single chain vitamin K-dependent glycoprotein which is synthesized in the liver. The domain structure of factor IX is similar to that of the other vitamin K dependent coagulation factors. The NH2-terminal region contains 12 γ-carboxyglutamic acid (gla) residues which facilitate the calcium dependent binding of factor IX to negatively charged phospholipid surfaces. Two domains which are homologous to epidermal growth factor (EGF) span the region between the NH2-terminal gla domain and the activation peptide (Ala-146 to Arg-180).Factor IX is activated by either factor XIa or the factor VIIa/tissue factor/phospholipid complex. Cleavage at site A (see fig. activates factor X to factor Xa.Human factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Bovine factor IX is prepared from fresh citrated bovine plasma by a modification of the method described by Fujikawa et al. The purified proteins are supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay. Group: Zymogens. CAS No. 9001-28-9. Purity: >95% by SDS-PAGE. Factor IX. Mole weight: 55400. Stability: 12 months. Storage: -20°C. Source: Bovine. Bovine factor IX; Factor IX. Pack: 100 ug. Cat No: CZY-003. | |
| Edoxaban | Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with K i values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DU-176. CAS No. 480449-70-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10264. |  |
| Edoxaban tosylate | Edoxaban (DU-176b) tosylate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with K i s of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban tosylate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban tosylate can be used for preventing thromboembolic disease research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DU-176b. CAS No. 480449-71-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-10264A. | |
| Edoxaban Tosylate | Used (in the form of its monohydrate) for the treatment of deep vein thrombosis and pulmonary embolism. It has a role as an anticoagulant, an EC 3.4.21.6 (coagulation factor Xa) inhibitor and a platelet aggregation inhibitor. Alternative Names: Edoxaban tosilate DU-176b Edoxaban (tosylate). CAS No. 480449-71-6. Product ID: API480449716. Molecular formula: C31H38ClN7O7S2. Mole weight: 720.3. EINECS: 852-705-5. SMILES: CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C. Appearance: White to Off-White Solid. Standard: Facility GMP. |  |
| Edoxaban tosylate monohydrate | Edoxaban (DU-176b) monohydrate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with K i s of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban monohydrate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban monohydrate can be used for preventing thromboembolic disease research [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DU-176b monohydrate. CAS No. 1229194-11-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10264B. | |
| Eribaxaban | Eribaxaban is an orally active inhibitor of coagulation factor Xa (activated factor X). It has anticoagulant activity and is used as an anticoagulant drug. It is used for the treatment and prevention of thrombotic disorders. It inhibited arterial thrombosis comparable to aspirin plus clopidogrel. It was developed by Pfizer. It was in phase II clinical trials, but has been terminated. Uses: Eribaxaban has anticoagulant activity and is used as an anticoagulant drug. it is used for the treatment and prevention of thrombotic disorders. Synonyms: PD348292; PD-348292; PD 348292; PD0348292; PD-0348292; PD 0348292; PD348,292; PD-348,292; PD 348,292; Eribaxaban; (2R,4R)-N1-(4-Chlorophenyl)-N2-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide. Grade: 98%. CAS No. 536748-46-6. Molecular formula: C24H22ClFN4O4. Mole weight: 484.91. | |
| Gabexate mesylate | Gabexate mesylate (FOY) is is a competitive and non-antigenic synthetic inhibitor of trypsin-like serine proteinases. Gabexate mesylate inhibits human thrombin, urokinase, plasmin, and Factor Xa with K i s of 0.97, 1.3, 1.6, and 8.5 μM, respectively. Gabexate mesylate binds to human and bovine tryptase with K i s of 3.4 nM and 18 μM, respectively. Gabexate mesylate exerts an anticoagulant effect on the clotting activity of thrombin and has anti-inflammatory effect by viainhibition of NF-κB, proinflammatory cytokines, and nitric oxide. Gabexate mesylate is used for pancreatitis and disseminated intravascular coagulation [1] [2] [3] [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FOY. CAS No. 56974-61-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0385. | |
| Heparin Sodium | Heparin sodium is a sodium salt of heparin which is a naturally-occurring anticoagulant used for anticoagulation for cardiovascular disease. It is an inhibitor of activated coagulation factors such as Factors Xa and IIa (thrombin). Alternative Names: Nadroparin Sodium. Heparin sodium salt (MW 15kDa). sodium;2-[3,5-bis(2-hydroxyethyl)-1,3,5-triazinan-1-yl]ethanolate. CAS No. 9041-8-1. Product ID: API9041081. Molecular formula: C9H20N3NaO3. Mole weight: 241.26. SMILES: C1N(CN(CN1CCO)CC[O-])CCO.[Na+]. Appearance: White or Off-white Powder. Standard: USP/EP/BP/IP. | |
| Heparin Sodium | Heparin sodium is a sodium salt of heparin which is a naturally-occurring anticoagulant used for anticoagulation for cardiovascular disease. It is an inhibitor of activated coagulation factors such as Factors Xa and IIa (thrombin). Uses: Anticoagulation for cardiovascular disease. Synonyms: Adomiparin Sodium; Alfa 87-120; Ardeparin Sodium; Badyket; Bemiparin Sodium; Dalteparin Sodium; Deligoparin Sodium; Depo-Heparin; Fragmin; Hepaflush; Hepagumin; Hepalean; Heprinar; Hepsal; Lipo-Hepin; Liquaemin Sodium; Logiparin; Longheparin; Minolteparin Sodium; Monoparin; Nadroparine Sodium; Normiflo; Panheprin; Parnaparin Sodium; Pularin; Reviparin Sodium; Semuloparin Sodium; Sevuparin Sodium; Sodium Acid Heparin; Sodium Heparin; Sodium Heparinate; Thrombo-Hepin. CAS No. 9041-8-1. Molecular formula: (C12H16NS2Na3)20. Mole weight: 6000-20000. | |
| Heparin sodium salt | Heparin sodium salt (Sodium heparin) is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa. Heparin sodium salt significantly inhibits exosome-cell interactions. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Sodium heparin; Sodium heparinate. CAS No. 9041-8-1. Pack Sizes: 100 mg; 500 mg; 1 g. Product ID: HY-17567A. | |
| Heparin sodium salt (MW 15kDa) | Heparin sodium salt (MW 15kDa) (Sodium heparin (MW 15kDa)) is a polymer of Heparin with the molecular weight of 15kDa. Heparin sodium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Sodium heparin (MW 15kDa); Sodium heparinate (MW 15kDa). CAS No. 9041-8-1. Pack Sizes: 100 mg; 500 mg. Product ID: HY-17567C. | |
| Human Coagulation Factor VII | Human factor VII is a single chain, vitamin K-dependent, plasma glycoprotein which is synthesized in the liver. Prior to secretion into the blood, post translational modification by a vitamin K-dependent carboxylase produces ten-carboxyglutamic acid (gla) residues located in the NH2-terminal portion of the molecule, which facilitate cell membrane binding. Factor VII is proteolytically activated to the serine protease, factor VIIa, during coagulation. Factor VII can be activated by thrombin, factor IXa, factor Xa or factor XIIa. The activation results in cleavage of the single chain molecule on the COOH-terminal side of arginine-152, to produce an NH2-terminal derived light chai.nzyme complex catalyzes the conversion of both factor IX to factor IXa and factor X to factor Xa. The cDNA for factor VII has been isolated and the nucleotide sequence determined. Factor VII shares extensive sequence homology with other serine proteases including factor IX, factor X and protein C.Human factor VII is purified using a combination of conventional techniques and immunoaffinity chromatography. The purified protein is supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured in a factor VII clotting assay. Group: Zymogens. CAS No. 9001-25-6. Purity: >95% by SDS-PAGE. Factor VII. Mole weigh. | |
| Human Factor IX | The zymogen factor IX is a single chain vitamin K-dependent glycoprotein which is synthesized in the liver. The domain structure of factor IX is similar to that of the other vitamin K dependent coagulation factors. The NH2-terminal region contains 12 γ-carboxyglutamic acid (gla) residues which facilitate the calcium dependent binding of factor IX to negatively charged phospholipid surfaces. Two domains which are homologous to epidermal growth factor (EGF) span the region between the NH2-terminal gla domain and the activation peptide (Ala-146 to Arg-180).Factor IX is activated by either factor XIa or the factor VIIa/tissue factor/phospholipid complex. Cleavage at site A (see fig.lly activates factor X to factor Xa.Human factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Bovine factor IX is prepared from fresh citrated bovine plasma by a modification of the method described by Fujikawa et al. The purified proteins are supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay. Group: Zymogens. CAS No. 9001-28-9. Purity: >95% by SDS-PAGE. Factor IX. Mole weight: 55000. Stability: 12 months. Storage: -20°C. Source: Human. Human Factor IX; Factor IX. Pack: 100 ug. Cat No: CZY-002. | |
| Mouse factor IX | The zymogen factor IX is a single chain vitamin K-dependent glycoprotein which is synthesized in the liver. The domain structure of factor IX is similar to that of the other vitamin K dependent coagulation factors. The NH2-terminal region contains 12 γ-carboxyglutamic acid (gla) residues which facilitate the calcium dependent binding of factor IX to negatively charged phospholipid surfaces. Two domains which are homologous to epidermal growth factor (EGF) span the region between the NH2-terminal gla domain and the activation peptide (Ala-146 to Arg-180).Factor IX is activated by either factor XIa or the factor VIIa/tissue factor/phospholipid complex. Cleavage at site A (see fig.factor VIIIa/IXa/Ca2+/phospholipid) which proteolytically activates factor X to factor Xa.Human factor IX is prepared from fresh frozen plasma by a combination of conventional procedures and immunoaffinity chromatography. Bovine factor IX is prepared from fresh citrated bovine plasma by a modification of the method described by Fujikawa et al. The purified proteins are supplied in 50% (vol/vol) glycerol/H2O and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured using a factor IX clotting assay. Group: Zymogens. Purity: >95%. Factor IX. Mole weight: 55000. Storage: -20°C. Source: Mouse. Mouse factor IX; Factor IX. Pack: 50 ug. Cat No: CZY-032. | |
| Native Bovine Factor X Activated (Xa) | Factor Xa catalyzes the hydrolysis of the Arg-Thr and then Arg-Ile bonds in prothrombin to yield active thrombin. The fairly strict recognition sequence is Ile-Glu (or Asp)-Gly-Arg-↓-X. It may sometimes cleave at other basic residues, depending on the conformation of the target protein. Factor Xa will not cleave if a proline residue follows the arginine of the recognition sequence. Factor xa is a serine endoproteinase and a member of the s1 peptidase family. factor xa plays a critical role in the coagulation cascade by catalyzing the proteolytic conversion of prothrombin to active thrombin. factor xa?s prothrombin conversion activity is greatly enhanced in vivo when c.d with 10 μg of factor xa for 2.5 hours at 37 oc. Group: Enzymes. Synonyms: EC 3.4.21.6; 9002-05-5; thrombokinase; prothrombase; prothrombinase; activated blood-coagulation factor X; autoprothrombin C; thromboplastin; plasma thromboplastin; factor Xa; activated Stuart-Prower factor; activated factor X; coagulation factor Xa. Enzyme Commission Number: EC 3.4.21.6. CAS No. 9002-5-5. Factor Xa. Storage: -20°C. Form: aqueous glycerol solution. Source: Bovine plasma. Species: Bovine. EC 3.4.21.6; 9002-05-5; thrombokinase; prothrombase; prothrombinase; activated blood-coagulation factor X; autoprothrombin C; thromboplastin; plasma thromboplastin; factor Xa; activated Stuart-Pr. | |
| Rivaroxaban | Rivaroxaban is an orally active, direct inhibitor of Factor Xa (Ki = 0.4 nM), which is a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade.1 It demonstrates >10,000-fold greater selectivity for Factor Xa compared to other related serine proteases.1 In various animal arterial and venous thrombosis models, rivaroxaban is reported to inhibit thrombin formation without prolonging bleeding time and has been approved for clinical use as an anticoagulant in the prevention of stroke and the treatment of venous thromboembolisms. Group: Biochemicals. Alternative Names: 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; BAY 59-7939. Grades: Highly Purified. CAS No. 366789-02-8. Pack Sizes: 100mg, 250mg, 500mg. Molecular Formula: C19H18ClN3O5S, Molecular Weight: 435.88. US Biological Life Sciences. | Worldwide |
| scutelarin | From the venom of the Taipan snake (Oxyuranus scutellatus). Converts prothrombin to thrombin. Specificity is similar to that of Factor Xa (EC 3.4.21.6). However, unlike Factor Xa this enzyme can cleave its target in the absence of coagulation Factor Va. Activity is potentiated by phospholipid and Ca2+ which binds via γ-carboxyglutamic acid residues. Similar enzymes are known from the venom of other Australian elapid snakes, including Pseudonaja textilis textilis, Oxyuranus microlepidotus and Demansia nuchalis affinis. Group: Enzymes. Synonyms: taipan activator; Oxyuranus scutellatus prothrombin-activating proteinase. Enzyme Commission Number: EC 3.4.21.60. CAS No. 93389-45-8. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4151; scutelarin; EC 3.4.21.60; 93389-45-8; taipan activator; Oxyuranus scutellatus prothrombin-activating proteinase. Cat No: EXWM-4151. | |
| 2-((5-Chloropyridin-2-yl)amino)-2-oxoacetic Acid | 2-((5-Chloropyridin-2-yl)amino)-2-oxoacetic Acid is a reactant or reagent used in the synthesis of the blood coagulating enzyme factor Xa (FXa) inhibitor. Group: Biochemicals. Grades: Highly Purified. CAS No. 552850-73-4. Pack Sizes: 1g, 5g. Molecular Formula: C7H5ClN2O3, Molecular Weight: 200.58. US Biological Life Sciences. | Worldwide |
| Ciraparantag | Ciraparantag is a thrombin and factor Xa inhibitor. Ciraparantag is a broad-spectrum reversal agent for anticoagulants, including low-molecular-weight heparin, unfractionated heparin, and certain direct oral anticoagulants. It is reported to antagonize the effects of all coagulants except VKAs and agratroban [1] [2] [3] [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PER977. CAS No. 1438492-26-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-18660. | |
Our database is helping our users find suppliers everyday.
